About Curemark
Curemark is a private company based in Rye Brook, New York. It has reported $77,709,323 raised in 13 offerings on Form D since June 2009. Its chief executive is Joan Fallon.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 30, 2023 | Mar 27, 2023 | $1,295,000of $15.0M target | 5 | $259K | OptionsRule 506(b) | Form D ↗ |
| Mar 24, 2021 | Apr 14, 2021 | $1,500,000of $5.0M target | 2 | $750K | EquityRule 506(b) | Form D ↗ |
| Aug 29, 2019 | Sep 11, 2019 | $5,405,000of $50.0M target | 1 | $5.4M | EquityRule 506(b) | Form D ↗ |
| Apr 11, 2018 | Apr 26, 2018 | $1,675,000of $3.0M target | 1 | $1.6M | OptionsRule 506(b) | Form D ↗ |
| Jan 15, 2018 | Jan 29, 2018 | $3,245,000of $80.0M target | 1 | $3.2M | EquityRule 506(b) | Form D ↗ |
| Mar 6, 2017 | Mar 20, 2017 | $3,000,000of $150.0M target | 2 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Jun 26, 2015 | Jul 13, 2015 | $20,250,000of $29.5M target | 2 | $10.1M | OptionsRule 506(b) | Form D ↗ |
| Dec 30, 2014 | Jan 14, 2015 | $5,000,000of $17.5M target | 1 | $5.0M | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 28, 2013 | Jan 14, 2014 | $18,752,466of $20.0M target | 66 | $284K | EquityRule 506(b) | Form D ↗ |
| Feb 28, 2012 | Mar 14, 2012amended Feb 5, 2013 | $6,042,000of $15.0M target | 37 | $163K | Debt, Options06 | Form D/A ↗1 earlier filing |
| Jul 16, 2010 | Jul 29, 2010 | $5,220,000of $10.0M target | 3 | $1.7M | Equity06 | Form D ↗ |
| Not yet | Feb 22, 2010 | $0of $10.0M target | 0 | — | Equity06 | Form D ↗ |
| Nov 21, 2008 | Jun 19, 2009 | $6,324,857of $6.5M target | 110 | $57,499 | Equity06 | Form D/A ↗ |
| Total, 13 offerings | $77,709,323 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Curemark's Form D filed Mar 27, 2023.
Earlier filings also listed Kimbell Duncan (director, last listed Apr 2021), Jzaneen Lalani (executive officer, last listed Sep 2019), Jennifer Frist (director, last listed Sep 2019), Justin Stebbing (director, last listed Apr 2018), Eric Hermann (director, last listed Apr 2018), Eric Herman (director, last listed Jul 2015), Klaus Kleinfeld (director, last listed Jan 2015) and Elisa Zinberg (executive officer, last listed Jul 2010).